House Bill 46, which awaits Gov. Greg Abbott’s approval, would include more patients with chronic pain and allow for ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

Texas senators voted unanimously May 27 to expand the state’s Compassionate Use Program. The latest version of House Bill 46 ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

Airborne microplastics and nanoplastics are increasingly detected in urban environments, with evidence linking inhalation ...

Five years after the world essentially shut down in response to the Coronavirus Pandemic, there is still a lot we don’t know about COVID-19.